ARIAD Pharma (ARIA) – Analyst Comments
-
Barclays Upgrades ARIAD Pharmaceuticals (ARIA) to Equalweight
-
Goldman Expects Oncology M&A To Be Active In 2017, Sees (GILD), (JNJ), (PFE), (MRK), (NVS), (SNY), (LLY) As Possible Acquirers
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ARIA Stock Lookup